Geode Capital Management’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.6M Buy
2,019,795
+54,985
+3% +$507K ﹤0.01% 1999
2025
Q1
$16.9M Buy
1,964,810
+89,888
+5% +$771K ﹤0.01% 1985
2024
Q4
$20.1M Sell
1,874,922
-8,277
-0.4% -$88.9K ﹤0.01% 1969
2024
Q3
$10.7M Buy
1,883,199
+51,946
+3% +$295K ﹤0.01% 2339
2024
Q2
$7.73M Buy
1,831,253
+118,526
+7% +$500K ﹤0.01% 2482
2024
Q1
$8.72M Buy
1,712,727
+47,363
+3% +$241K ﹤0.01% 2401
2023
Q4
$15.5M Buy
1,665,364
+92,396
+6% +$860K ﹤0.01% 2064
2023
Q3
$10.3M Buy
1,572,968
+30,668
+2% +$201K ﹤0.01% 2249
2023
Q2
$12.5M Buy
1,542,300
+89,422
+6% +$727K ﹤0.01% 2150
2023
Q1
$12.5M Buy
1,452,878
+47,414
+3% +$406K ﹤0.01% 2117
2022
Q4
$13M Buy
1,405,464
+79,536
+6% +$736K ﹤0.01% 2076
2022
Q3
$13.7M Buy
1,325,928
+13,706
+1% +$141K ﹤0.01% 2016
2022
Q2
$13.1M Buy
1,312,222
+4,385
+0.3% +$43.9K ﹤0.01% 2062
2022
Q1
$16.1M Buy
1,307,837
+10,466
+0.8% +$129K ﹤0.01% 2029
2021
Q4
$22.5M Buy
1,297,371
+99,262
+8% +$1.72M ﹤0.01% 1871
2021
Q3
$21.5M Buy
1,198,109
+40,537
+4% +$728K ﹤0.01% 1911
2021
Q2
$26.5M Buy
1,157,572
+121,887
+12% +$2.79M ﹤0.01% 1783
2021
Q1
$15.5M Buy
1,035,685
+242,093
+31% +$3.62M ﹤0.01% 2040
2020
Q4
$4.29M Buy
793,592
+42,775
+6% +$231K ﹤0.01% 2681
2020
Q3
$3.42M Buy
750,817
+30,092
+4% +$137K ﹤0.01% 2602
2020
Q2
$3.55M Buy
720,725
+3,144
+0.4% +$15.5K ﹤0.01% 2520
2020
Q1
$2.26M Buy
717,581
+104,462
+17% +$329K ﹤0.01% 2607
2019
Q4
$1.59M Buy
613,119
+24,271
+4% +$62.8K ﹤0.01% 3105
2019
Q3
$1.86M Buy
588,848
+37,085
+7% +$117K ﹤0.01% 2976
2019
Q2
$1.86M Buy
551,763
+222,915
+68% +$751K ﹤0.01% 2997
2019
Q1
$1M Buy
328,848
+36,900
+13% +$112K ﹤0.01% 3162
2018
Q4
$455K Buy
291,948
+3,687
+1% +$5.75K ﹤0.01% 3408
2018
Q3
$786K Buy
288,261
+7,156
+3% +$19.5K ﹤0.01% 3315
2018
Q2
$736K Sell
281,105
-44,482
-14% -$116K ﹤0.01% 3302
2018
Q1
$898K Buy
325,587
+7,068
+2% +$19.5K ﹤0.01% 3169
2017
Q4
$1.03M Buy
318,519
+7,740
+2% +$24.9K ﹤0.01% 3088
2017
Q3
$1.29M Buy
310,779
+11,297
+4% +$46.7K ﹤0.01% 3004
2017
Q2
$1.59M Buy
299,482
+22,508
+8% +$120K ﹤0.01% 2865
2017
Q1
$1.59M Buy
276,974
+39,934
+17% +$229K ﹤0.01% 2783
2016
Q4
$938K Buy
237,040
+7,075
+3% +$28K ﹤0.01% 3024
2016
Q3
$834K Buy
229,965
+3,677
+2% +$13.3K ﹤0.01% 3034
2016
Q2
$1.38M Buy
226,288
+46,739
+26% +$285K ﹤0.01% 2722
2016
Q1
$879 Buy
179,549
+57,572
+47% +$282 ﹤0.01% 2950
2015
Q4
$679K Buy
+121,977
New +$679K ﹤0.01% 3110